Julie Earl completed her PhD at the University of Liverpool, UK, in 2002 and her postdoctoral studies at the University of Liverpool from 2002–2008 and the Spanish Cancer Research Center (CNIO) in Madrid, Spain, from 2008–2011. She is a senior researcher in the Medical Oncology department of the university hospital Ramon y Cajal, Madrid, Spain, since 2011 and specializes ´ in cancer genetics and tumor biomarkers, particularly in digestive cancers. She is the coordinator of the Spanish familial pancreatic cancer registry and her lines of research include the genetics of familial pancreatic cancer and the use of the liquid biopsy for the identification and validation of tumor biomarkers. Currently, the group are performing whole exome sequencing to identify novel genes associated with familial cancer and also developing and validating liquid biopsy based tumor markers as prognostic and diagnostic tools. This includes Circulating Tumor Cells (CTC) detection and circulating free tumor DNA detection (cftDNA) in plasma. She is a member of the board of the liquid biopsy group of the Biomedical Research Network in Cancer (CIBERONC) and the coordinator of the in vitro tumor models platform of her institute. She has published more than 40 articles and currently actively participates in several national and international projects related with pancreatic oncology research.